Cite
HARVARD Citation
Groome, M. et al. (2020). Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial. Lancet infectious diseases. 20 (7), pp. 851-863. [Online].